Skip to main content

Portfolio

HBM Healthcare Investments holds and manages a well-balanced portfolio with high value-creation potential.

Overview as at 31 December 2024

Currency allocation of assets

Emphasis on US dollar investments

56 340 US dollar (USD) 61 Euro (EUR) 14 Renminbi (CNY) 10 Indian rupee (INR) 7 Swiss franc (CHF) 3 Other currencies (CAD, DKK, GBP, HDK, SEK) 5 #87b164 #cb2648 #8c74af #00a4c8 #dc6c3f #e5ae1f #49753d #21659a #cab415 #423e3d
Allocation of assets

Mainly invested in private companies or in companies originating
from the private companies portfolio.

62 340 Private companies 31 Public (from private) companies 26 Public companies 23 Funds 10 Cash and cash equivalents 8 Other assets 2 #87b164 #cb2648 #8c74af #00a4c8 #dc6c3f #e5ae1f #49753d #21659a #cab415 #423e3d
Development phase of portfolio companies

Mainly invested in revenue generating companies or in companies with products at an advanced stage of development.

69 90 Profitable 40 Products on the market 22 Phase I 5 Phase II 23 Phase III 7 Preclinical 3 #87b164 #cb2648 #8c74af #00a4c8 #dc6c3f #e5ae1f #49753d #21659a #cab415 #423e3d
Therapeutic area of the lead product of portfolio companies

Broadly diversified areas of activity.

79 350 Others 27 Oncology 17 Central nervous system 13 Synthetic biology 11 Immunology/Inflammation 11 Digital Health 8 Orphan diseases 8 Medical technology / diagnostics 5 #87b164 #cb2648 #8c74af #00a4c8 #dc6c3f #e5ae1f #49753d #21659a #cab415 #423e3d